Gossamer Bio Inc. GOSS) on Friday reported a loss of $46.7 million in its first quarter. The San Diego-based company said it had a loss of 20 cents per share.

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. The company is headquartered in Dallas, Texas.

TELA Bio, Inc. ( NASDAQ:TELA ) shareholders are probably feeling a little disappointed, since its shares fell 10.0% ...

Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a biotechnology company focused on identifying and advancing innovative therapeutics, today reported its first quarter 2026 financial results and provided a ...

First Reporting Quarter as Valion Bio Marked by Continued Advancement of the Entolimod Platform, Broader Government Engagement, and Continued Integration of Velocity ...

Welcome to Valion Bio, Inc.'s conference call to discuss first quarter 2026 financial results. This call has been prerecorded. The call is being webcast, and the replay will be available on the ...

The live audio webcast can be accessed on the Investors section of Adicet Bio’s website at http://www.adicetbio.com. An archived replay will be available for 30 days following the presentation.

Adaptin Bio, Inc. (OTCQB: APTN), ('Adaptin” or the 'Company”), a biotechnology company developing precision cancer ...

Preconditioning-free (PC-free) 6-to-9-month clinical data with a single infusion of the lowest dose of rese-cel in the RESET-PV- study presented today at ASGCT 2026 Annual Meeting along with initial ...

Bank of America Global Healthcare Conference 2026 May 13, 2026 11:00 AM EDTCompany ParticipantsDavid Hung - Founder, President, ...

As cases of Alzheimer's disease climb worldwide and governments sharpen their focus on biodefense, the absence of efficient pathways for delivering drugs to the brain is fast becoming one of ...